BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25397417)

  • 1. Difference in factors associated with low-level viraemia and virological failure: results from the Austrian HIV Cohort Study.
    Leierer G; Rieger A; Steuer A; Sarcletti M; Geit M; Haas B; Taylor N; Kanatschnig M; Rappold M; Ledergerber B; Zangerle R
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19667. PubMed ID: 25397417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study.
    Leierer G; Grabmeier-Pfistershammer K; Steuer A; Geit M; Sarcletti M; Haas B; Kanatschnig M; Rappold M; Zangerle R; Ledergerber B; Taylor N;
    PLoS One; 2015; 10(11):e0142923. PubMed ID: 26566025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
    Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
    Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.
    Álvarez H; Rava M; Martínez C; Portilla J; Peraire J; Rivero A; Cervero M; Mariño A; Poveda E; Llibre JM;
    HIV Med; 2022 Sep; 23(8):825-836. PubMed ID: 35234328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating rates and predictors of viral blips, low-level viraemia and virological failure in the Australian HIV observational database.
    Han WM; Broom J; Bopage R; Templeton DJ; Edmiston N; Petoumenos K;
    Trop Med Int Health; 2024 Jan; 29(1):42-56. PubMed ID: 38009461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study.
    Sudjaritruk T; Teeraananchai S; Kariminia A; Lapphra K; Kumarasamy N; Fong MS; Hansudewechakul R; Bunupuradah T; Ly PS; Nallusamy RA; Sohn AH; Sirisanthana V;
    J Int AIDS Soc; 2020 Jul; 23(7):e25550. PubMed ID: 32628816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of low-level viraemia on virological failure in HIV-1-infected patients with stable antiretroviral treatment.
    Navarro J; Caballero E; Curran A; Burgos J; Ocaña I; Falcó V; Torrella A; Pérez M; Ribera E; Crespo M
    Antivir Ther; 2016; 21(4):345-52. PubMed ID: 26756461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective observational study of low-level viraemia and its immunological and virological significance: which outcome to expect.
    Silva J; Pereira K; Rijo J; Alberto T; Cabanas J; Gomes P; Farinha H; Mansinho K
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19668. PubMed ID: 25397418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
    Bareng OT; Moyo S; Zahralban-Steele M; Maruapula D; Ditlhako T; Mokaleng B; Mokgethi P; Choga WT; Moraka NO; Pretorius-Holme M; Mine MO; Raizes E; Molebatsi K; Motswaledi MS; Gobe I; Mohammed T; Gaolathe T; Shapiro R; Mmalane M; Makhema JM; Lockman S; Essex M; Novitsky V; Gaseitsiwe S
    J Antimicrob Chemother; 2022 Apr; 77(5):1385-1395. PubMed ID: 35229102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study.
    Lao X; Zhang H; Deng M; Li Q; Xiao Q; He L; Ma L; Song A; Liang X; Yu F; Zhao H; Zhang F
    BMC Infect Dis; 2024 Jan; 24(1):8. PubMed ID: 38166689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study.
    Brattgård H; Björkman P; Nowak P; Treutiger CJ; Gisslén M; Elvstam O
    PLoS One; 2022; 17(5):e0268540. PubMed ID: 35580115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort.
    Zhang T; Ding H; An M; Wang X; Tian W; Zhao B; Han X
    BMC Infect Dis; 2020 Feb; 20(1):147. PubMed ID: 32066392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of low-level viraemia in diverse settings: analysis of the Treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD).
    Kanapathipillai R; McManus H; Cuong DD; Ng OT; Kinh NV; Giles M; Read T; Woolley I
    HIV Med; 2014 Aug; 15(7):406-16. PubMed ID: 24460817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression.
    Elén S; Björkman P; Zazzi M; Böhm M; Bernal E; Sönnerborg A; Elvstam O;
    HIV Med; 2024 Jan; 25(1):107-116. PubMed ID: 37721192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 low-level viraemia predicts virological failure in first-line and second-line ART-experienced individuals in India: A retrospective longitudinal study.
    Dinesha TR; Boobalan J; Kumar CV; Manikandan P; Muhila M; Solomon SS; Srikrishnan AK; Murugavel KG
    HIV Med; 2024 Jul; 25(7):852-861. PubMed ID: 38663865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study.
    Leierer G; Grabmeier-Pfistershammer K; Steuer A; Sarcletti M; Geit M; Haas B; Taylor N; Kanatschnig M; Rappold M; Ledergerber B; Zangerle R
    Open Forum Infect Dis; 2016 Apr; 3(2):ofw089. PubMed ID: 27419163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Low-Level Viraemia on Virological Failure-Results From a Multicenter HIV Antiretroviral Therapy Cohort Study in Yunnan, China.
    An J; Lao Y; Tang S; Lou J; Li T; Dong X
    Front Med (Lausanne); 2022; 9():939261. PubMed ID: 35860732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort.
    Elvstam O; Malmborn K; Elén S; Marrone G; García F; Zazzi M; Sönnerborg A; Böhm M; Seguin-Devaux C; Björkman P
    Clin Infect Dis; 2023 Jan; 76(1):25-31. PubMed ID: 36100984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV: how to manage low-level viraemia in people living with HIV.
    Hanners EK; Benitez-Burke J; Badowski ME
    Drugs Context; 2022; 11():. PubMed ID: 35310296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.